Dividend compounder review

AMRX

Amneal Pharmaceuticals, Inc. Class A Common Stock · NASDAQ · US

Healthcare · Drug Manufacturers - Specialty & Generic

Chart Factor Intelligence Back to Screener
Score46.50/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 14.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 17.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.5 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 12.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$72.1M
Free Cash Flow$225.6M
FCF Covers DividendUnknown
Debt / Equity67.51
P/E43.8
Revenue Growth 5Y8.7%
Net Margin4.0%
ROE-2.7%
Price vs Trend24.0%
3Y Return462.5%
5Y Return203.4%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Debt to equity is elevated at 67.51.
Dividend diary

Activity record

AMRX dividend review warning Warning · Warning

Debt to equity is elevated at 67.51.